

Merck KGaA is acquiring Bio-Techne in an $11.3B all-cash deal to expand its life science, diagnostics, and bioprocessing footprint.
You can purchase shares of Bio-Techne (NASDAQ:TECH) through any online brokerage.
Other companies in Bio-Techne’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Bio-Techne has a consensus price target of $72.17.
The stock price for Bio-Techne (NASDAQ: TECH) is $72.78 last updated November 6, 2026 at 4:00 PM EST.
There are no upcoming dividends for Bio-Techne.
Bio-Techne does not have any upcoming earnings scheduled.
There is no upcoming split for Bio-Techne.
Bio-Techne is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and...